Gamma Knife Market Size, Share, Opportunities, And Trends By Disease (Brain Metastasis, Cancer, Arteriovenous Malformation, Trigeminal Neuralgia, Others), By Anatomy (Head, Neck, Others), By Distribution Channel (Online, Offline), And By Geography - Forecasts From 2023 To 2028

The gamma knife market was valued at US$573.416 million in 2021 and is expected to grow at a CAGR of 5.91% during the forecast period.

The Gamma Knife is a specialized medical device used for non-invasive radiosurgery, specifically targeting brain tumors and other neurological conditions. The growing prevalence of brain tumors and other neurological disorders are major growth drivers of the gamma knife market. Moreover, the rising aging population, increasing awareness among healthcare providers and patients, and increasing implementation of the imaging software are further expected to propel the gamma knife market.

Increasing Prevalence of Brain Tumors

The gamma knife system uses a highly accurate guidance system and specialized collimators to precisely focus multiple radiation beams on the target. This accuracy allows for effective treatment while minimizing radiation exposure to healthy brain tissue. Therefore, increasing the incidence of brain tumors is expected to boost the gamma knife market. For instance, an estimated 308,102 people were diagnosed with brain tumors in 2020 as per the American Society of Clinical Oncology. According to The Brain Tumor Charity Organization, brain tumors reduce life expectancy by an average of 27 years which is the highest of any cancer.

Increasing Prevalence of Neurological Disorders

The gamma knife is an effective treatment option for various neurological disorders.  For example, selected arteriovenous malformations (AVMs) can be treated by gamma knife radiosurgery by focusing radiation on the aberrant vessels, causing them to progressively seal off over time. Moreover, it has been investigated that gamma knife radiosurgery may be used to treat movement disorders such as essential tremors and Parkinson's disease. Therefore, the rising prevalence of Parkinson’s disease and movement disorders is expected to propel the gamma knife market. For instance, around 42 million US population suffers from movement disorder according to recent data from the University of Michigan Health.

Rising Implementation of Imaging Software

Imaging software plays a crucial role in the planning and execution of gamma knife radiosurgery. Imaging software enables the precise delineation of the target lesion or pathology, ensuring accurate targeting during gamma knife treatment. Three-dimensional (3D) imaging capabilities, along with specialized algorithms and tools, facilitate the creation of treatment plans that optimize radiation delivery while minimizing exposure to surrounding healthy tissue. The advancements in imaging software are therefore anticipated to boost the gamma knife market. For instance, Intelerad Medical Systems launched Enterprise Imaging and Informatics Suite at the 2022 Global Health Conference and Exhibition in March 2022 to develop an integrated hub with centralized patient data.

Growing Geriatric Population

The prevalence of brain tumors and other neurological illnesses is higher in the aging population as per the NCBI study. Therefore, the need for efficient treatment solutions like the gamma knife is anticipated to rise as the world's population continues to age. For instance, the percentage of people aged over 60 years worldwide will increase from 12% to 22% between 2015 and 2050 as per the WHO. Additionally, the number of people aged 60 years or above is estimated to increase from 1 billion in 2020 to 1.4 billion in 2030 as per the WHO reports.

Increasing Awareness and Education

The awareness among patients and healthcare professionals about the benefits of Gamma Knife radiosurgery is growing. Educational initiatives, online resources, and information sharing have played a crucial role in increasing the adoption of Gamma Knife treatments thereby aiding the gamma knife market. For instance, the Gamma Knife Training Program was initiated by UT Southwestern Medical Center in September 2021. It was developed for individuals who are new to the gamma knife system.

Restraints in the Market

The gamma knife market has experienced growth and development however some restraints or challenges can impact its expansion. For example, Gamma Knife systems are complex and specialized medical equipment, and their high price might be a major impediment to adoption. Healthcare institutions may find it difficult to integrate Gamma Knife technology into their treatment options because of the initial equipment investment, continuing maintenance costs, and operating costs. Moreover, Gamma Knife systems need specialized equipment and qualified medical personnel, which may restrict their availability in some areas or healthcare institutions, particularly in backward nations.

North America is expected to grow Considerably

North America is expected to hold a significant share of the gamma knife market during the forecast period. The factors attributed to such a share are the rising cases of brain tumors, strong healthcare facilities, research, and awareness initiatives, and a growing elderly population. For instance, around 25,000 new cases of malignant brain tumors or spinal cord tumors are estimated to be diagnosed in 2023 as per the American Cancer Society. Moreover, the number of people aged 60 years or above are projected to reach 80.8 million by 2040 from 54.1 million in 2019 as per the CDC data as this age group has a high chance of developing brain cancer. Thus, it will also drive the gamma knife market in the region.

Major Market Players

• Elekta is a prominent player in the Gamma Knife market and a leading global healthcare company specializing in radiation therapy, radiosurgery, and clinical solutions for cancer and brain disorders. Elekta offers the Leksell Gamma Knife, which is a widely recognized and utilized Gamma Knife system.
• Beaumont Health is a not-for-profit healthcare system based in the United States. It offers radiosurgery treatment using a gamma knife to cure benign tumors such as acoustic neuromas, meningiomas, and pituitary adenomas.
• Intermountain Healthcare focuses on delivering high-quality, patient-centered care through a range of medical services including neurosurgery and radiation therapy using gamma knife.

Key Market Developments

• In December 2022, the new Gamma Knife® Icon™ center was opened at Weill Cornell Medical Center in Newyork. It is operated jointly by the Department of Radiation Oncology and Neurology Surgery to provide best-in-class care for patients with brain tumors and other disorders.
• In May 2022, Elekta launched a new radiosurgery system named Elekta Espirit to enable more personalized radiosurgery with sub-millimeter accuracy. It provides the treatment team with better visualization, remote accessibility, and collaboration features.
• In May 2020, Elekta launched Leksell Gamma Knife® lightning for intracranial stereotactic radiosurgery. It is a fully integrated automated treatment planning solution for gamma knives.

Segmentation:

• By Disease
  • Brain Metastasis
  • Cancer
  • Arteriovenous Malformation
  • Trigeminal Neuralgia
  • Others
• By Anatomy
  • Head
  • Neck
  • Others
• By Distribution Channel
  • Online
  • Offline
• By Geography
  
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • United Kingdom
    • Germany
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • UAE
    • Israel
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Indonesia
    • Thailand
    • Others